You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



Adult ADHD: Patient-Centered Treatment for the Complex Case

  • Authors: Gregory W. Mattingly, MD; David Goodman, MD; Joel L. Young, MD
  • CME / CE Released: 6/16/2022
  • Valid for credit through: 7/14/2022
Start Activity

Target Audience and Goal Statement

This activity is intended for psychologists, primary care physicians, pediatricians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare providers who manage adults with attention deficit hyperactivity disorder (ADHD).

The goal of this activity is that learners will be better able to differentiate ADHD from other psychiatric disorders in adults and individualize treatment of ADHD, with a focus on nonstimulants.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Differentiation of ADHD from other psychiatric conditions in adult patients
    • Considerations of comorbidities when selecting treatment for adult patients with ADHD
  • Have greater competence related to
    • Selecting a nonstimulant medication in appropriate patients with ADHD
  • Demonstrate greater confidence in their ability to
    • Incorporate interprofessional strategies for care of adult patients with ADHD


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Gregory W. Mattingly, MD

    Associate Clinical Professor
    The Washington University School of Medicine
    St. Louis, Missouri


    Gregory W. Mattingly, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Acadia; Alkermes; Axsome; Corium; Eisai; Ironshore; Intracellular; Janssen; Lundbeck; Neos; Neurocrine; Noven; Otsuka; Redax; Roche; Rhodes; Sage; Sunovion; Supernus; Takeda; Teva; Tris Pharma
    Research funding from: AbbVie; Alkermes; Corium; Eisai; Intracellular; Ironshore; Janssen; Lundbeck; Neurocrine; Noven; Otsuka; Sunovion; Supernus; Takeda; Tris Pharma
    Contracted researcher for: AbbVie; Acadia; Alkermes; Akili; Axsome; Boehringer Ingelheim; Emalex; Idorsia; Janssen; Karuna; Lumos Labs; Medgenics; NLS-1 Pharma AG; Redax; Relmada; Roche; Sage; Sirtsei; Sunovion; Supernus; Takeda; Teva

  • David W. Goodman, MD

    Assistant Professor
    Department of Psychiatry and Behavioral Sciences
    Johns Hopkins School of Medicine
    Baltimore, Maryland


    Participation by Dr David W. Goodman does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.
    David W. Goodman, MD, has the following relevant financial relationships:
    Consultant or advisor for: Adlon Pharm; Clinical Care Solutions; HCPlive; Ironshore Pharmaceuticals; Neos Therapeutics; Neuroscience Education Institute; NLS Pharma; Noven; Ondosis; Otsuka Pharmaceuticals; Shionogi; Sunovion; Supernus; Takeda; Teva Pharmaceuticals; Tris Pharma
    Stock options from: Kempharm

  • Joel L. Young, MD

    Medical Director
    Rochester Center for Behavioral Medicine
    Rochester Hills, Michigan
    Clinical Associate Professor
    Wayne State University School of Medicine
    Detroit, Michigan


    Joel L. Young, MD, has the following relevant financial relationships:
    Consultant or advisor for: Corium; Janssen; Noven; Supernus
    Speaker or member of speakers bureau for: Alkermes; Axsome; Corium; Ironshore; Janssen; Otsuka; Sunovion; Supernus; Tris
    Research funding from: Janssen; Jazz; Otsuka


  • Kathy Merlo

    Medical Education Director, Medscape, LLC


    Kathy Merlo has no relevant financial relationships. 

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC 


    Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) (Universal Activity Number: JA0007105-0000-22-140-L01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Adult ADHD: Patient-Centered Treatment for the Complex Case

Authors: Gregory W. Mattingly, MD; David Goodman, MD; Joel L. Young, MDFaculty and Disclosures

CME / CE Released: 6/16/2022

Valid for credit through: 7/14/2022


This certificate page is associated with a Medscape Education event.

Earn Credit

  • Print